These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 14707072)

  • 21. Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses.
    Sumida K; Wakita D; Narita Y; Masuko K; Terada S; Watanabe K; Satoh T; Kitamura H; Nishimura T
    Eur J Immunol; 2012 Aug; 42(8):2060-72. PubMed ID: 22653638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye.
    McKenna KC; Kapp JA
    J Immunol; 2006 Aug; 177(3):1599-608. PubMed ID: 16849468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
    Fernández A; Mesa C; Marigo I; Dolcetti L; Clavell M; Oliver L; Fernández LE; Bronte V
    J Immunol; 2011 Jan; 186(1):264-74. PubMed ID: 21135171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.
    Almand B; Clark JI; Nikitina E; van Beynen J; English NR; Knight SC; Carbone DP; Gabrilovich DI
    J Immunol; 2001 Jan; 166(1):678-89. PubMed ID: 11123353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.
    Nagaraj S; Schrum AG; Cho HI; Celis E; Gabrilovich DI
    J Immunol; 2010 Mar; 184(6):3106-16. PubMed ID: 20142361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
    Corzo CA; Cotter MJ; Cheng P; Cheng F; Kusmartsev S; Sotomayor E; Padhya T; McCaffrey TV; McCaffrey JC; Gabrilovich DI
    J Immunol; 2009 May; 182(9):5693-701. PubMed ID: 19380816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic regulation of IFN-gamma signaling in antigen-specific CD8+ T cells responding to infection.
    Haring JS; Corbin GA; Harty JT
    J Immunol; 2005 Jun; 174(11):6791-802. PubMed ID: 15905520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
    Nefedova Y; Nagaraj S; Rosenbauer A; Muro-Cacho C; Sebti SM; Gabrilovich DI
    Cancer Res; 2005 Oct; 65(20):9525-35. PubMed ID: 16230418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses.
    Ghansah T; Paraiso KH; Highfill S; Desponts C; May S; McIntosh JK; Wang JW; Ninos J; Brayer J; Cheng F; Sotomayor E; Kerr WG
    J Immunol; 2004 Dec; 173(12):7324-30. PubMed ID: 15585856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity.
    Weinhold M; Sommermeyer D; Uckert W; Blankenstein T
    J Immunol; 2007 Oct; 179(8):5534-42. PubMed ID: 17911640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function.
    Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC
    Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
    Apolloni E; Bronte V; Mazzoni A; Serafini P; Cabrelle A; Segal DM; Young HA; Zanovello P
    J Immunol; 2000 Dec; 165(12):6723-30. PubMed ID: 11120790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.